The Effect of Tamsulosin on Postoperative Urinary Retention
Stopped early · Phase 4 · Has a placebo group
Conditions studied: Urinary Retention
In brief
This is a double-blinded randomized controlled trial of perioperative use of tamsulosin to prevent postoperative urinary retention in female pelvic reconstructive surgery undergoing same-day discharge with an enhanced recovery after surgery protocol.
Key facts
- Study ID
- NCT04682366
- Run by
- Wake Forest University Health Sciences
- People needed
- 4
- Starts
- 2021-10-19
- Expected to finish
- 2022-11-10
- Last updated by the study team
- 2024-01-31
Who can join
Age: 21 and older, up to 99. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Stage II or greater pelvic organ prolapse in > 1 vaginal compartment
- Plan for multicompartment native tissue vaginal repair (which would include any combination of uterosacral ligament suspension, sacrospinous ligament suspension, cystocele and/or rectocele repair, with or without hysterectomy and with or without concomitant mid-urethral sling) or vaginal closure with female pelvic medicine and reconstructive surgery (FPMRS) - trained surgeons at Wake Forest Baptist Health
- Participation in Enhanced-Recovery-After-Surgery protocol with plan for same-day hospital discharge
- Willing to remain compliant with Investigation Product (IP)
You may not qualify if…
- Intraoperative complication necessitating prolonged bladder drainage or placement of a vaginal pack x 24 hours (patients would exit study after randomization and will be excluded from the per-protocol analysis)
- Patients whose surgical plan would necessitate a voiding trial on postop day >0
- Less than 21 years of age
- Unable to understand English
- Patients who are scheduled to undergo combined colorectal procedures such as rectopexy, sphincteroplasty
- Patient with known allergy to Tamsulosin or sulfa drugs
- Patients with upcoming cataract surgery
- Patient with orthostatic hypotension
- History of postvoid residual (PVR>150) prior to surgery with prolapse reduction
- Patients with hypertension on alpha-blockers
- Single compartment prolapse repair (anterior or posterior repair only)
- Use of mesh for prolapse repair
- High tone pelvic floor dysfunction
Where it is running
- Wake Forest Health Sciences — Winston-Salem, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.